维普中文期刊产品整合服务
46篇 您的检索式:作者名="SALAGIANNI M"
    题名 作者 年代 出处 被引量
1Toll-like receptor 7protects from atherosclerosis by constraining“inflammatory”macrophage activation显示文摘Salagianni M Galani IE Lundberg AM 2012Circulation2012,126,8:1
2Toll-like receptor 7 protects from atherosclemsis by constraining 'inflammatory' macrephage activa- tion显示文摘Salagianni M Galani IE Lundberg AM 2012Circulation2012,126,8:1
3Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells显示文摘Sotiropoulou PA Perez SA Salagianni M 2006Stem Cells2006,24,2:1
4An essential role for IL-18 in CD8 T cell-mediated suppression of IgE responses显示文摘Salagianni M Wong KL Thomas M J 2007J Immunol2007,178,8:1
5Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells 显示文摘Sotiropoulou PA Perez SA Salagianni M 2006Stem Cells2006,24,:1
6Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells显示文摘Sotiropoulou PA Perez SA Salagianni M 2006Stem Cells2006,24,2:1
7Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells 显示文摘SOTIROPOULOU P A PEREZ S A SALAGIANNI M 2006Stem Cells2006,24,2:1
8Charac- terization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells显示文摘Sotiropoulou PA Perez SA Salagianni M 2006Stem Cells2006,24,:1
9Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells 显示文摘Sotiropoulou PA Perez SA Salagianni M 2006Stem Cells2006,24,2:1
10Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cel s显示文摘Sotiropoulou PA Perez SA Salagianni M 0,,02:1
11Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells 显示文摘Sotiropoulou P A Perez S A Salagianni M 2006Stem Cells2006,24,2:1
12Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells 显示文摘Sotiropoulou PA Perez SA Salagianni M 2006Stem Cells2006,24,2:1
13Character- ization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells 显示文摘Sotiropoulou PA Perez SA Salagianni M 2006Stem Cells2006,24,2:1
14New insights into the role of NK cells in cancer immunotherapy 显示文摘Salagianni M Baxevanis CN Papamichail M 2012Oncoimmunology2012,1,2:1
15New insights into the role of NK cells in cancer immunotherapy显示文摘Salagianni M Baxevanis CN Papamichail M et aI 2012Oncoimmunology2012,1,2:1
16Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells 显示文摘Sotiropoulou PA Perez SA Salagianni M 2006Stem Cells2006,24,2:1
17An essential role for IL-18 in CD8 T cell-mediated suppression of IgE responses显示文摘Salagianni M Wong KL Thomas MJ 0,,:1
18NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses显示文摘Salagianni M Lekka E Moustaki A 2011J hnmunol2011,186,6:1
19Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells 显示文摘Sotiropoulou P A Perez S A Salagianni M 2006Stem Cells2006,24,2:1
20Toil-likereceptor 7 protects from atherosclerosis by constraining“inflammatory” macrophage activation 显示文摘Salagianni M Galani IE Lundberg AM 2012Circulation2012,126,8:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费